Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 431-437

  Nakamura, Yoshio ^a   Kogure, Kentaro ^a,b   Yamada, Yuma ^a   Futaki, Shiroh ^b,c   Harashima, Hideyoshi ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ANTISENSE OLIGODEOXYNUCLEOTIDE; ARGININE DERIVATIVE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FLUORESCEIN ISOTHIOCYANATE; LIGAND; LIPOFECTAMINE; LUCIFERASE; PLASMID DNA; POLYCATION; POLYLYSINE; PROTAMINE SULFATE; RHODAMINE; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ARTICLE; DEVICE; ENCAPSULATION; GENETIC TRANSFECTION; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TOXICITY TESTING;

AMINO ACID SEQUENCE; ANIMALS; MICE; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; NIH 3T3 CELLS; OLIGONUCLEOTIDES, ANTISENSE; PLASMIDS; TIME FACTORS; TRANSFECTION;

EID: 33645569141     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.4.0002     Document Type: Article

References (21)

1. Brewer, L. R., Corzett, M., Balhorn, R. (1999) Protamine-induced condensation and decondensation of the same DNA molecule. Science 286: 120-123
2. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima H., Sugiura, Y. (2001) Stearylated arginine-rich peptides: a new class of transfection system. Bioconjug. Chem. 12: 1005-1011
3. Gokhale, P. C., Soldatenkov, V., Wang, F. H., Rahman, A., Dritschilo, A., Kasid, U. (1997) Antisense raf oligodeoxyribo-nucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer. Gene Ther. 4: 1289-1299
4. Kakudo, T., Chaki, S., Futaki, S., Nakase, K. I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., Harashima, H. (2004) Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 18: 5618-5628
5. Khalil, I. A., Futaki, S., Niwa, M., Baba, Y., Kaji, N., Kamiya, H., Harashima, H. (2004) Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11: 636-644
6. Kogure, K., Moriguchi, R., Sasaki, K., Ueno, M., Futaki, S., Harashima, H. (2004) Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98: 317-323
7. Masuda, T., Akita, H., Harashima, H. (2005) Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: the use of a nuclear transfer score. FEBS Lett. 579: 2143-2148
8. Miyake, H., Hara, I., Kamidono, S., Gleave, M. (2001) Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity. Int. J. Urol. 8: 337-349
9. Moriguchi, R., Kogure, K., Akita, H., Futaki, S., Miyagishi, M., Taira, K., Harashima, H. (2005) A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm. 301: 277-285
10. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., Jones, A. T., Sugiura, Y., Futaki, S. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10: 1011-1022
11. Phillips, M. I. (2001) Gene therapy for hypertension. Hypertension 38: 543-548
12. Sasaki, K., Kogure, K., Chaki, S., Kihira, Y., Ueno, M., Harashima, H. (2005) Construction of multifunctional envelope-type nano device by a SUV*-fusion method. Int. J. Pharm. 296: 142-150
13. Scherer, L. J., Rossi, J. J. (2003) Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21: 1457-1465
14. Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., Scherrer, P. (2001) Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta 1510: 152-166
15. Shi, F., Hoekstra, D. (2004) Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J. Control. Release 97: 189-209
16. Sorgi, F. L., Bhattacharya, S., Huang, L. (1997) Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 4: 961-968
17. Stephenson, M. L., Zamecnik, P. C. (1978) Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl Acad. Sci. USA 75: 285-288
18. Xu, Y., Zhang, H. Y., Thormeyer, D., Larsson, O., Du, Q., Elmen, J., Wahlestedt, C., Liang, Z. (2003) Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem. Biophys. Res. Commun. 306: 712-717
19. Yamada, Y., Shinohara, Y., Kakudo, T., Chaki, S., Futaki, S., Kamiya, H., Harashima, H. (2005a) Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int. J. Pharm. 299: 34-40
20. Yamada, Y., Kogure, K., Nakamura, Y., Inoue, K., Akita, H., Nagatsugi, F., Sasaki, S., Suhara, T., Harashima, H. (2005b) Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure. Biol. Pharm. Bull. 28: 1939-1942
21. Zamecnik, P. C., Stephenson, M. L. (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligonucleotide. Proc. Natl Acad. Sci. USA 75: 280-284